LYVE1 Antikörper (AA 25-235)
Kurzübersicht für LYVE1 Antikörper (AA 25-235) (ABIN165430)
Target
Alle LYVE1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 25-235
-
Verwendungszweck
- Human LYVE-1 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human LYVE-1 (25-235 aa) purified from E. coli
-
Isotyp
- IgG2b kappa
-
-
-
-
Applikationshinweise
- Recommended dilution 1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Andere Bezeichnung
- LYVE-1
-
Hintergrund
- Lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1), a selective marker of the lymphatic endothelium, is a surface endocytic receptor for hyaluronan (HA), which is an extracellular glycosaminoglycan involved in cell adhesion and migration. HA is widely expressed on leukocytes, dendritic cells, and tumor cell, and is identified by searching expressed sequence tag (EST) databases for sequences homologous (41 % ) with the metastasis related CD44 Molecules.
-
NCBI Accession
- NP_006682
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-